What Does The Future Hold For This Marijuana Stock
Tetra Bio-Pharma, Inc. and Constance Theraputics
Although the legal cannabis industry is the fastest growing industry in the world, many investors look over some of the best opportunities.
While many people view the cultivation and retail opportunities as the sexiest, we continue to see value within the biotech side of the business.
One company focused on this opportunity is Tetra Bio-Pharma Inc. (TBP.CN) (TBPMF) and it has flown under the radar this year. We believe this is a stock investors need to watch as it continues to work to create enormous value for its shareholders.
Sings LOI with Constance Therapeutics
Last month, Tetra signed a letter of intent with San Francisco-based Constance Therapeutics for the clinical development and commercialization of its patent-pending medicinal cannabis extract products in Canada.
Constance Therapeutics works in conjunction with physicians and medical professionals to provide integrative medicinal options to those suffering from serious conditions. Tetra’s AgroTek Health subsidiary will work with Constance to bring these products to the Canadian medical marijuana market under a commercial license agreement.
Tetra also said it will enter a licensing agreement with Constance to perform clinical research on the novel cannabis extract products, initially focusing on their use in treating patients with brain cancer. These products are currently available to patients living in California and are consumed sublingually and through vaporization.
Continue reading at MarijuanaStocks.com
Don’t forget to like and subscribe to WeedTV @yourweedtv